We are live on ! Find out more
CG

Cynosure Group Portfolio holdings

AUM $666M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+18.54%
3 Year Est. Return
+56.82%
5 Year Est. Return
+68.46%
10 Year Est. Return
–
AUM
$188M
AUM Growth
+$3.79M
Cap. Flow
-$16.4M
Cap. Flow %
-8.76%
Top 10 Hldgs %
82.7%
Holding
68
New
–
Increased
1
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$54.6K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$6.83M
2
UNP icon
Union Pacific
UNP
+$5.94M
3
GE icon
GE Aerospace
GE
+$3.71M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$19.8K

Sector Composition

Rank Sector Weight
1 Industrials 40.23%
2 Miscellaneous 27.06%
3 Financials 20.4%
4 Technology 4.18%
5 Healthcare 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
26
Citigroup
C
$228B
$650K 0.35%
8,133
– –
INTC icon
27
Intel
INTC
$513B
$603K 0.32%
10,076
– –
ADI icon
28
Analog Devices
ADI
$175B
$583K 0.31%
4,908
– –
JNJ icon
29
Johnson & Johnson
JNJ
$644B
$569K 0.3%
3,898
– –
DIS icon
30
Walt Disney
DIS
$184B
$567K 0.3%
3,921
– –
TMO icon
31
Thermo Fisher Scientific
TMO
$237B
$561K 0.3%
1,726
– –
DHR icon
32
Danaher
DHR
$147B
$519K 0.28%
3,815
– –
MCD icon
33
McDonald's
MCD
$179B
$516K 0.27%
2,610
– –
EEM icon
34
iShares MSCI Emerging Markets ETF
EEM
$30.6B
$507K 0.27%
11,300
– –
IWM icon
35
iShares Russell 2000 ETF
IWM
$76.9B
$507K 0.27%
3,060
– –
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$499K 0.27%
7,768
+953
+14% +$54.6K
WMT icon
37
Walmart Inc
WMT
$858B
$485K 0.26%
12,249
– –
SPY icon
38
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$479K 0.26%
1,487
– –
PG icon
39
Procter & Gamble
PG
$341B
$477K 0.25%
3,817
– –
META icon
40
Meta Platforms (Facebook)
META
$1.71T
$460K 0.25%
2,243
– –
TFC icon
41
Truist Financial
TFC
$61.6B
$459K 0.24%
8,154
– –
MS icon
42
Morgan Stanley
MS
$324B
$457K 0.24%
8,937
– –
HON icon
43
Honeywell
HON
$64.5B
$448K 0.24%
2,685
– –
RTX icon
44
RTX Corp
RTX
$263B
$439K 0.23%
4,659
– –
CSCO icon
45
Cisco
CSCO
$434B
$430K 0.23%
8,972
– –
PYPL icon
46
PayPal
PYPL
$46B
$430K 0.23%
3,979
– –
MDLZ icon
47
Mondelez International
MDLZ
$79.3B
$425K 0.23%
7,718
– –
AGN
48
DELISTED
Allergan plc
AGN
$418K 0.22%
2,185
– –
QCOM icon
49
Qualcomm
QCOM
$201B
$413K 0.22%
4,680
– –
T icon
50
AT&T
T
$183B
$392K 0.21%
13,278
– –
1
2
3

Similar funds

AG
Advocate Group Minnetonka, Minnesota $665M AUM 22.13% 1-Year Est. Return
CCM
Cantillon Capital Management New York $665M AUM 25.91% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
SC
Steginsky Capital Port Washington, New York $666M AUM 34.57% 1-Year Est. Return
AGWCA
Annis Gardner Whiting Capital Advisors Tampa, Florida $666M AUM 28.24% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $666M AUM 5.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Cynosure Group's Q4 2019 Portfolio in Review

As of Q4 2019, Cynosure Group held 68 positions worth $188M, up 2.1% from $184M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Cynosure Group withdrew a net $16.4M in Q4 2019, reducing 4 holdings. Its largest reduction was Wells Fargo, cutting an estimated $6.83M.

By sector, the portfolio is most concentrated in Industrials at 40% of assets, up from 40% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Cynosure Group added an estimated $54.6K to Bristol-Myers Squibb.

  • Cynosure Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $54.6K increase.
  • Cynosure Group's biggest Q4 2019 reduction was Wells Fargo, cutting an estimated $6.83M.
  • Cynosure Group's ten largest holdings make up 83% of its $188M portfolio in Q4 2019.
  • Cynosure Group opened 0 new positions and closed 0 in Q4 2019.
  • Cynosure Group's portfolio value rose 2.1% quarter-over-quarter to $188M.

Based on Cynosure Group's 13F filing for Q4 2019, filed 4 Feb 2020.